Lunaldin in the Treatment of Breakthrough Pain: Results of Non-Interventional Study

Abstract

In the BTcP treatment both pharmacological and non-pharmacological approaches are applied, neverthless transmucosal fentanyl formulations play the most important role. Evaluation of their effectiveness and safety was the subject of multicentric non-interventional study, which was held in the Czech Republic beginning from January to December, 2011.

Keywords

• breakthrough pain
• carcinoma
• effectiveness
• fentanyl
• safety
• sublingual administration
• transmucosal